Cohen Klingenstein’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $502K | Hold |
4,000
| – | – | 0.02% | 182 |
|
2025
Q1 | $547K | Hold |
4,000
| – | – | 0.02% | 180 |
|
2024
Q4 | $612K | Hold |
4,000
| – | – | 0.02% | 178 |
|
2024
Q3 | $775K | Hold |
4,000
| – | – | 0.03% | 180 |
|
2024
Q2 | $927K | Hold |
4,000
| – | – | 0.03% | 168 |
|
2024
Q1 | $863K | Hold |
4,000
| – | – | 0.03% | 176 |
|
2023
Q4 | $1.04M | Hold |
4,000
| – | – | 0.04% | 167 |
|
2023
Q3 | $1.03M | Hold |
4,000
| – | – | 0.05% | 160 |
|
2023
Q2 | $1.14M | Hold |
4,000
| – | – | 0.05% | 157 |
|
2023
Q1 | $1.11M | Hold |
4,000
| – | – | 0.05% | 156 |
|
2022
Q4 | $1.11M | Hold |
4,000
| – | – | 0.06% | 158 |
|
2022
Q3 | $1.07M | Hold |
4,000
| – | – | 0.06% | 152 |
|
2022
Q2 | $816K | Hold |
4,000
| – | – | 0.04% | 169 |
|
2022
Q1 | $842K | Hold |
4,000
| – | – | 0.04% | 174 |
|
2021
Q4 | $960K | Hold |
4,000
| – | – | 0.04% | 174 |
|
2021
Q3 | $1.13M | Hold |
4,000
| – | – | 0.05% | 168 |
|
2021
Q2 | $1.39M | Hold |
4,000
| – | – | 0.06% | 154 |
|
2021
Q1 | $1.12M | Hold |
4,000
| – | – | 0.05% | 173 |
|
2020
Q4 | $979K | Hold |
4,000
| – | – | 0.05% | 172 |
|
2020
Q3 | $1.14M | Hold |
4,000
| – | – | 0.06% | 152 |
|
2020
Q2 | $1.07M | Hold |
4,000
| – | – | 0.07% | 154 |
|
2020
Q1 | $1.27M | Hold |
4,000
| – | – | 0.09% | 129 |
|
2019
Q4 | $1.19M | Hold |
4,000
| – | – | 0.07% | 149 |
|
2019
Q3 | $931K | Buy |
+4,000
| New | +$931K | 0.06% | 169 |
|